ClinicalTrialsFinder

High-risk Prostate Cancer Clinical Trials in Portland, Oregon

1 recruitingPortland, Oregon

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

High-risk Prostate Cancer
VA Office of Research and Development30 enrolled6 locationsNCT05593497